Effect of risperidone dose on serum prolactin level

Endocrine Practice

Volumn 7, Issue 3, 2001, Pages 224-

  Daniels, G H ^a   Hayden, D L ^a   Goff, D C ^a   Kearns, A E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; PROLACTIN; RISPERIDONE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; HYPERPROLACTINEMIA; LETTER; MALE; PROLACTIN BLOOD LEVEL; STATISTICAL ANALYSIS;

EID: 0034985609     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/ep.7.3.224     Document Type: Letter

References (2)

1. Antipsychotic drug-induced hyperprolactinemia: Clinical implications
2. Prolactin levels and adverse events in patients treated with risperidone